Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
39.12
+0.94 (2.46%)
At close: Dec 10, 2025, 4:00 PM EST
39.10
-0.02 (-0.05%)
After-hours: Dec 10, 2025, 4:10 PM EST
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $2.1 billion as of December 10, 2025. Its market cap has increased by 318.74% in one year.
Market Cap
2.10B
Enterprise Value
1.81B
1-Year Change
318.74%
Ranking
Category
Stock Price
$39.12
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $2.10B, an increase of 210.42%. That is a compound annual growth rate of 149.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 2.10B | 513.22% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.77B |
| Johnson & Johnson | 487.01B |
| AbbVie | 397.26B |
| UnitedHealth Group | 293.97B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 246.02B |
| Novo Nordisk | 214.27B |